ADVANCED MEDICAL DEVICE TECHNOLOGIES, INC

ADVANCED MEDICAL DEVICE TECHNOLOGIES, INC specializes in the design, development, and manufacturing of advanced medical devices compliant with FDA regulatory frameworks and ISO 13485 quality standards. Leveraging expertise in electro-mechanical system integration, biocompatible materials engineering, and real-time embedded firmware development, the company delivers precision diagnostic and therapeutic devices for clinical and point-of-care environments. Their technical focus includes miniaturized sensor arrays, low-power wireless telemetry, and FDA-cleared Class II device platforms with validated software validation (SVVP) and risk management per IEC 62304. Differentiators include in-house prototyping capabilities, rapid iterative testing cycles, and experience navigating 510(k) submission pathways with robust design control documentation. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal partnership can be inferred. Consequently, there is no verifiable record of direct work with HHS, DoD, VA, or other federal entities. The company’s primary NAICS code, 339112, reflects its core function as a medical equipment and supplies manufacturer, with practical emphasis on electromedical and electrotherapeutic apparatus production. This positions the firm within the high-regulation medical device vertical, serving hospitals, clinics, and private-label distributors requiring FDA-compliant, ISO-certified hardware. Market positioning centers on niche, high-reliability devices where regulatory rigor and technical precision outweigh volume production. As a 2L entity based in Las Vegas, NV, ADVANCED MEDICAL DEVICE TECHNOLOGIES, INC operates as a small, specialized manufacturer without federal certifications such as 8(a), HUBZone, or WOSB. The company maintains a focused geographic footprint with no indication of multi-site operations or federal contracting offices beyond its Nevada base. Its business model prioritizes engineering excellence and regulatory compliance over broad federal market penetration.